Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bastens

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Acta Gastro-Enterologica Belgica|August 10, 2010
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patientsF Nevens, H Van Vlierberghe, E D'Heygere, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 11, 2017
The Belgian national registry on chronic pancreatitis: A prospective multi-centre study covering more than 800 patients in one yearM Fernandez, M Arvanitakis, C Musala, et al.
Acta Gastro-Enterologica Belgica|May 14, 2011
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registryS Francque, S De Maeght, M Adler, et al.
Alimentary Pharmacology & Therapeutics|July 1, 2004
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral responseJ Delwaide, N Bourgeois, C Gérard, et al.
Acta Gastro-Enterologica Belgica|August 25, 2011
Hepatitis C of genotype 2: the role of medical invasive examsV Putzeys, C Gérard, B Bastens, et al.
Acta Gastro-Enterologica Belgica|May 13, 2010
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust studyH Van Vlierberghe, M Adler, B Bastens, et al.
Journal of Viral Hepatitis|November 25, 2003
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialH Van Vlierberghe, G Leroux-Roels, M Adler, et al.
Journal of Medical Virology|July 1, 2015
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsA Arain, S Bourgeois, C de Galocsy, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Acta Gastro-Enterologica Belgica|August 10, 2010
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patientsF Nevens, H Van Vlierberghe, E D'Heygere, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 11, 2017
The Belgian national registry on chronic pancreatitis: A prospective multi-centre study covering more than 800 patients in one yearM Fernandez, M Arvanitakis, C Musala, et al.
Acta Gastro-Enterologica Belgica|May 14, 2011
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registryS Francque, S De Maeght, M Adler, et al.
Alimentary Pharmacology & Therapeutics|July 1, 2004
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral responseJ Delwaide, N Bourgeois, C Gérard, et al.
Acta Gastro-Enterologica Belgica|August 25, 2011
Hepatitis C of genotype 2: the role of medical invasive examsV Putzeys, C Gérard, B Bastens, et al.
Acta Gastro-Enterologica Belgica|May 13, 2010
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust studyH Van Vlierberghe, M Adler, B Bastens, et al.
Journal of Viral Hepatitis|November 25, 2003
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialH Van Vlierberghe, G Leroux-Roels, M Adler, et al.
Journal of Medical Virology|July 1, 2015
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsA Arain, S Bourgeois, C de Galocsy, et al.
Pageof 3